Although overall tumor size after seven days of treatment with FGFR and ALK inhibitors was not affected when compared with vehicle, there was a significant reduction in cancer cell proliferation as measured by the number of mitotic figures (Figure 2E,F) and a reduction in the number of tumor-infiltrating capillaries (Figure 2E,G). The gene discussed is ALK; the disease is cancer.